BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38650318)

  • 1. Cardiac and Intramuscular Metastases Following Nephroureterectomy for Metachronous Urothelial Carcinoma.
    Chan HY; Chan WY; Wong Su Lin J
    Am J Case Rep; 2024 Apr; 25():e942864. PubMed ID: 38650318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac metastasis of renal pelvic cancer.
    Murakami T; Komiya A; Mikata K; Kaneko S; Ikeda I
    Int J Urol; 2007 Mar; 14(3):240-1. PubMed ID: 17430263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.
    Li X; Cui M; Gu X; Fang D; Li H; Qin S; Yang K; Zhu T; Li X; Zhou L; Gao XS; Wang D
    World J Surg Oncol; 2020 May; 18(1):114. PubMed ID: 32473636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transitional cell carcinoma with extension of the renal vein and IVC tumor thrombus: report of three cases and literature review.
    Li M; Shi A; Kong W; Zhang J; Chen Y; Huang J; Huang Y
    World J Surg Oncol; 2016 Dec; 14(1):309. PubMed ID: 28031042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site of metastatic recurrence impacts prognosis in patients with high-grade upper tract urothelial carcinoma.
    Cheaib JG; Claus LE; Patel HD; Kates MR; Matoso A; Hahn NM; Bivalacqua TJ; Hoffman-Censits JH; Pierorazio PM
    Urol Oncol; 2021 Jan; 39(1):74.e9-74.e16. PubMed ID: 33071108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right ventricular metastasis of transitional cell carcinoma of the renal pelvis: successful single stage surgical treatment.
    Shields AM; Pomplun S; Deshpande R; Whitaker DC
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):297-300. PubMed ID: 21051378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma.
    Silberstein JL; Power NE; Savage C; Tarin TV; Favaretto RL; Su D; Kaag MG; Herr HW; Dalbagni G
    J Urol; 2012 Feb; 187(2):429-34. PubMed ID: 22177163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma.
    Yanagi M; Hamasaki T; Akatsuka J; Endo Y; Takeda H; Kondo Y
    BMC Urol; 2021 Dec; 21(1):167. PubMed ID: 34856960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative prognostic factors and atypical patterns of recurrence in patients with upper urinary tract urothelial carcinoma treated with laparoscopic radical nephroureterectomy.
    Carrion A; Huguet J; García-Cruz E; Izquierdo L; Mateu L; Musquera M; Ribal MJ; Alcaraz A
    Scand J Urol; 2016 Aug; 50(4):305-12. PubMed ID: 26926709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
    Liao RS; Gupta M; Schwen ZR; Patel HD; Kates M; Johnson MH; Hahn NM; McConkey D; Bivalacqua TJ; Pierorazio PM
    J Urol; 2018 Jul; 200(1):68-73. PubMed ID: 29307680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.
    Cho MH; Kim SH; Park WS; Joung JY; Seo HK; Chung J; Lee KH
    World J Surg Oncol; 2016 Oct; 14(1):270. PubMed ID: 27765044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome prediction following radical nephroureterectomy for upper tract urothelial carcinoma.
    Abdul-Muhsin H; De Lucia N; Singh V; Faraj K; Rose K; Cha S; Zhang N; Judge N; Navaratnam A; Tyson M; Ho T; Jacobsohn K; Castle E
    Urol Oncol; 2021 Feb; 39(2):133.e9-133.e16. PubMed ID: 33069555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer.
    Bree KK; Hensley PJ; Brooks NA; Matulay J; Li R; Nogueras Gonzalez GM; Navai N; Grossman HB; Matin SF; Dinney CPN; Kamat AM
    BJU Int; 2021 Nov; 128(5):568-574. PubMed ID: 33484074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robotic radical nephroureterectomy and segmental ureterectomy for upper tract urothelial carcinoma: a multi-institutional experience.
    Campi R; Cotte J; Sessa F; Seisen T; Tellini R; Amparore D; Mormile N; Gobert A; Mari A; Porpiglia F; Serni S; Minervini A; Rouprêt M
    World J Urol; 2019 Nov; 37(11):2303-2311. PubMed ID: 31062121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robot-assisted versus open radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: A retrospective cohort study across ten years.
    Zeuschner P; Vollmer SG; Linxweiler J; Wagenpfeil G; Wagenpfeil S; Saar M; Siemer S; Stöckle M; Heinzelbecker J
    Surg Oncol; 2021 Sep; 38():101607. PubMed ID: 34022505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac metastasis from a transitional cell carcinoma diagnosed by two-dimensional echocardiography.
    Kadono Y; Yamamoto H; Tajika E
    Int J Urol; 2006 Apr; 13(4):454-6. PubMed ID: 16734873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
    Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Conditional Survival with Time of Intravesical Recurrence of Upper Tract Urothelial Carcinoma.
    Shigeta K; Kikuchi E; Hagiwara M; Ando T; Mizuno R; Abe T; Mikami S; Miyajima A; Nakagawa K; Oya M
    J Urol; 2017 Dec; 198(6):1278-1285. PubMed ID: 28634017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines.
    Upfill-Brown A; Lenis AT; Faiena I; Salmasi AH; Johnson DC; Pooli A; Drakaki A; Gollapudi K; Blumberg J; Pantuck AJ; Chamie K
    World J Urol; 2019 Jun; 37(6):1157-1164. PubMed ID: 30267197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of upper tract urothelial carcinoma with isolated lymph node involvement following surgical resection: implications for multi-modal management.
    Pelcovits A; Mueller-Leonhard C; Mega A; Amin A; Kim SP; Golijanin D; Gershman B
    World J Urol; 2020 May; 38(5):1243-1252. PubMed ID: 31388818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.